Detalhe da pesquisa
1.
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer.
Immunity
; 56(1): 93-106.e6, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574773
2.
Phase and context shape the function of composite oncogenic mutations.
Nature
; 582(7810): 100-103, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461694
3.
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 577(7789): E1, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822847
4.
Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 571(7766): 576-579, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292550
5.
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Acta Neuropathol
; 147(1): 85, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758238
6.
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma.
Cancer
; 126(17): 3939-3949, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573775
7.
Environmental perturbations lead to extensive directional shifts in RNA processing.
PLoS Genet
; 13(10): e1006995, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023442
8.
High-throughput allele-specific expression across 250 environmental conditions.
Genome Res
; 26(12): 1627-1638, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27934696
9.
RNA-DNA differences in human mitochondria restore ancestral form of 16S ribosomal RNA.
Genome Res
; 23(11): 1789-96, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913925
10.
Interactions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes.
PLoS Genet
; 7(7): e1002162, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21750684
11.
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.
NPJ Precis Oncol
; 8(1): 34, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355834
12.
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.
Clin Cancer Res
; 30(4): 703-718, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695642
13.
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation.
J Thorac Oncol
; 18(9): 1222-1232, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210008
14.
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.
Clin Cancer Res
; 29(11): 2043-2051, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971773
15.
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
J Immunother Cancer
; 11(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914383
16.
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.
Nat Med
; 29(10): 2458-2463, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845474
17.
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
J Thorac Oncol
; 18(11): 1524-1537, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247843
18.
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma.
Clin Cancer Res
; 28(5): 939-947, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965948
19.
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.
J Immunother Cancer
; 10(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365586
20.
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma.
Nat Commun
; 13(1): 3477, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710741